nitisinone dipharma 20 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 20 mg
abiraterone glenmark 500 mg
glenmark arzneimittel gmbh - abirateronacetat - tablett, filmdrasjert - 500 mg
pirfenidone sandoz 801 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg
pirfenidone sandoz 267 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg
abiraterone qilu 500 mg
qilu pharma spain s.l. - abirateronacetat - tablett, filmdrasjert - 500 mg
abiraterone stada 500 mg
stada arzneimittel ag - abirateronacetat - tablett, filmdrasjert - 500 mg
pirfenidone newbury 267 mg
newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 267 mg
pirfenidone newbury 801 mg
newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 801 mg
competact
cheplapharm arzneimittel gmbh - pioglitazone, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.